July 30, 2026 · Form 4 insider transaction
Hayden Michael R bought 15,000 shares of Ionis Pharmaceuticals, Inc. at $53.38 per share, a transaction worth $800.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
The price reported in Column 4 is a weighted average price. These shares were purchase in multiple transactions at prices ranging from $53.00 to $53.58 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) on this Form 4.; These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2.